252004-49-2 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
(4-chloro-2,5-difluorophenyl)methanol is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. Its unique chemical structure allows for the development of new and effective compounds with potential applications in these industries.
Used in Organic Chemistry:
(4-chloro-2,5-difluorophenyl)methanol is also used in the production of other organic compounds. Its versatility as a halogenated alcohol makes it a valuable building block for the creation of a wide range of chemical products.
Used in Medicinal Chemistry and Drug Development:
Due to its unique chemical properties, (4-chloro-2,5-difluorophenyl)methanol may have potential applications in the field of medicinal chemistry and drug development. Researchers can utilize (4-chloro-2,5-difluorophenyl)methanol to explore new avenues in the design and synthesis of novel therapeutic agents.
Safety Precautions:
It is important to handle (4-chloro-2,5-difluorophenyl)methanol with care and follow proper safety protocols, as it may pose certain health and environmental risks if not used appropriately. Proper handling and disposal methods should be employed to minimize any potential hazards associated with (4-chloro-2,5-difluorophenyl)methanol.
Check Digit Verification of cas no
The CAS Registry Mumber 252004-49-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,0,0 and 4 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 252004-49:
(8*2)+(7*5)+(6*2)+(5*0)+(4*0)+(3*4)+(2*4)+(1*9)=92
92 % 10 = 2
So 252004-49-2 is a valid CAS Registry Number.
252004-49-2Relevant academic research and scientific papers
Isothiazole derivatives useful as anticancer agents
-
, (2008/06/13)
The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.
